Thalassemia pathology for neet pg 2026 visual aod

Reading Document
Medical Text Search

thalassemia pathology types alpha beta molecular defects hemolysis ineffective erythropoiesis

Medical Image Search

thalassemia pathology diagram blood smear target cells ineffective erythropoiesis

GradeResponse
GradeResponse
Here is a comprehensive NEET PG 2026-focused breakdown of Thalassemia Pathology — visual and high-yield.

🩸 Thalassemia — Pathology (NEET PG 2026)


Pathophysiology Diagram — Beta-Thalassemia

Beta-thalassemia pathophysiology
Molecular cascade from α:β imbalance → ineffective erythropoiesis → iron overload + chronic anemia

Core Concept: Globin Chain Imbalance

Featureβ-Thalassemiaα-Thalassemia
Gene affectedβ-globin gene (chr 11)α-globin gene (chr 16)
Mutation typePredominantly point mutationsPredominantly deletions
Excess chainα-chains accumulateβ, γ, Γ-chains accumulate
Tetramers formedα₄ (Heinz bodies)β₄ (HbH), γ₄ (Hb Barts)
Oā‚‚ affinity of tetramersN/A (precipitate)Very HIGH — do not deliver Oā‚‚

β-Thalassemia: Step-by-Step Pathology

Step 1 — Molecular Defect

  • Mutations in β-globin gene → reduced (β⁺) or absent (β⁰) β-chain synthesis
  • Result: Excess unpaired α-chains → cannot form stable tetramers → precipitate inside erythroblasts

Step 2 — Hemichrome Formation & ROS

  • Precipitated α-chains → hemichromes → generate reactive oxygen species (ROS)
  • ROS → membrane lipid peroxidation → erythroblast membrane damage

Step 3 — Ineffective Erythropoiesis ⭐ (Most Important Mechanism)

  • Damaged erythroblasts are destroyed within the bone marrow before entering circulation
  • This is called intramedullary hemolysis / ineffective erythropoiesis
  • Predominant cause of anemia in β-thalassemia (Harrison's, p. 2927)
  • GDF11/GDF15 signaling → ↑ p-SMAD2/3 → ↓ GATA1 → ↑ apoptosis of erythroid precursors

Step 4 — Peripheral Hemolysis (Minor Component)

  • Cells that escape into circulation: ↓ deformability + phosphatidylserine exposure → extravascular + intravascular hemolysis

Consequences of Ineffective Erythropoiesis

Severe Anemia
     ↓
Marrow Expansion (erythroid hyperplasia)
     ↓
ā”Œā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”¬ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”
│ Skeletal Changes         │ Extramedullary            │
│ • "Hair on end"          │ Hematopoiesis             │
│   skull X-ray            │ • Hepatosplenomegaly       │
│ • Crew-cut appearance    │ • Paraspinal masses        │
│ • Frontal bossing        │                           │
│ • Rodent facies          │                           │
ā””ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”“ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”˜
     ↓
Iron Overload (↑ GI absorption + transfusions)
     ↓
Hemosiderosis → Liver cirrhosis, Dilated CMP,
                Diabetes, Hypogonadism

Iron Overload Mechanism (High-Yield)

MediatorRole
ERFE (Erythroferrone)↑ in ineffective erythropoiesis → ↓ Hepcidin
Hepcidin↓ → ↑ Ferroportin activity → ↑ GI iron absorption
TfR1 (Transferrin Receptor 1)↑ on erythroblasts → increased iron uptake
NEET PG Key Point: Ineffective erythropoiesis → ↑ ERFE → ↓ Hepcidin → Iron overload. This is independent of transfusions.

α-Thalassemia: Clinical Spectrum

GenotypeAlleles deletedClinical Picture
Silent carrier-α/αα (1 deleted)Normal, asymptomatic
α-Thal trait--/αα or -α/-α (2 deleted)Mild microcytic anemia
HbH disease--/-α (3 deleted)Moderately severe hemolytic anemia, HbH (β₄ tetramers)
Hb Barts (Hydrops fetalis)--/-- (4 deleted)Incompatible with life, γ₄ tetramers, severe tissue hypoxia
HbH inclusions stain with brilliant cresyl blue — "golf ball" cells

β-Thalassemia: Clinical Classification

TypeGenotypeHb levelTransfusion
Thalassemia Minor (Trait)β/β⁺ or β/β⁰9–11 g/dLNot required
Thalassemia Intermediaβ⁺/β⁺6–9 g/dLOccasional
Thalassemia Major (Cooley's anemia)β⁰/β⁰<6 g/dLRegular transfusions

Hemoglobin Electrophoresis Findings

ConditionHbAHbA2HbF
Normal97%2.5%<1%
β-Thal Minor↓↑ (>3.5%) ⭐↑ slightly
β-Thal MajorAbsent/↓↓↑↑↑ (up to 90%)
α-Thal trait↓Normal/↓Normal
HbH disease↓↓Normal + HbH
NEET PG Key: HbA2 >3.5% = hallmark of β-thalassemia trait. Used for carrier screening.

Peripheral Blood Smear Findings

  • Microcytic hypochromic RBCs
  • Target cells (codocytes) ⭐
  • Nucleated RBCs (nRBCs) — due to marrow stress
  • Basophilic stippling
  • Poikilocytosis (tear drop cells, elliptocytes)
  • Elevated reticulocyte count (though paradoxically low given the degree of anemia)

Complications Summary (Thalassemia Major)

SystemComplication
CardiacDilated cardiomyopathy (iron) — #1 cause of death
LiverCirrhosis, hepatocellular carcinoma
EndocrineDiabetes, hypogonadism, hypothyroidism, short stature
BoneOsteoporosis, pathological fractures
ImmuneAsplenia (post-splenectomy) → encapsulated organisms

Treatment (NEET PG Essentials)

TreatmentDetails
Regular blood transfusionTarget Hb >10 g/dL; monthly
Iron chelationDesferrioxamine (IV/SC), Deferasirox (oral), Deferiprone (oral)
SplenectomyReduces transfusion requirement; risk of sepsis
Hydroxyurea↑ HbF production (β-thal intermedia)
LuspaterceptAnti-GDF11 → ↓ ineffective erythropoiesis (newer drug)
HSCT (Bone Marrow Transplant)Only curative option
Gene therapyBetibeglogene (Zynteglo) — approved for β-thalassemia

High-Yield One-Liners for NEET PG 2026

  1. Predominant mechanism of anemia in β-thalassemia = Ineffective erythropoiesis (not hemolysis)
  2. α-thalassemia = gene deletions; β-thalassemia = gene point mutations
  3. HbA2 >3.5% = β-thalassemia trait (carrier screening test)
  4. Hb Barts (γ₄) = 4-gene deletion α-thal = hydrops fetalis
  5. HbH (β₄) = 3-gene deletion = golf ball cells with BCB stain
  6. Ferritin ↑↑ in thalassemia major despite iron deficiency picture on smear (due to overload)
  7. Cardiac hemosiderosis = #1 cause of death in thalassemia major
  8. Curative treatment = Allogeneic HSCT
  9. Rodent facies + hair-on-end skull X-ray = thalassemia major (marrow expansion)
  10. Target cells on smear + microcytic anemia with normal/high serum iron = think thalassemia (not IDA)

Sources: Harrison's Principles of Internal Medicine, 21st Edition (p. 2927); PMC Clinical VQA — β-thalassemia pathophysiology diagram
This is a shared conversation. Sign in to Orris to start your own chat.